-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

Benzinga·10/15/2026 21:30:03
Diffusion vocale
UBS analyst Joon Lee initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $20.